Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase |
2025-03-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BLACKROCK INC BLK |
9,066,517 5.700% |
9,235 (+0.10%) |
Filing History |
| 2025-02-13 4:53 pm Purchase |
2024-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
Capital World Investors | 11,465,413 7.300% |
11,465,413 (New Position) |
Filing History |
| 2025-02-07 11:55 am Purchase |
2025-01-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
T. Rowe Price Investment Management, Inc. | 15,851,863 10.000% |
1,683,747 (+11.88%) |
Filing History |
| 2025-01-08 11:29 am Purchase |
2024-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
The Vanguard Group | 16,472,539 10.430% |
2,269,058 (+15.98%) |
Filing History |
| 2024-11-14 8:34 pm Sale |
2024-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB BIOTECH AG | 7,850,000 5.000% |
-740,000 (-8.61%) |
Filing History |
| 2024-11-14 1:28 pm Purchase |
2024-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS |
T. Rowe Price Investment Management, Inc. | 14,168,116 9.000% |
966,663 (+7.32%) |
Filing History |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS |
WELLINGTON MANAGEMENT CO LLP | 9,067,836 5.760% |
2,319,282 (+34.37%) |
Filing History |
| 2024-02-14 10:04 am Purchase |
2023-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
T. Rowe Price Investment Management, Inc. | 13,201,453 9.200% |
1,523,194 (+13.04%) |
Filing History |
| 2024-02-13 5:07 pm Sale |
2023-12-29 | 13G | Ionis Pharmaceuticals, Inc. IONS |
The Vanguard Group | 14,203,481 9.900% |
-211,436 (-1.47%) |
Filing History |
| 2024-02-13 06:09 am Sale |
2023-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB BIOTECH AG | 8,590,000 6.000% |
-1,045,000 (-10.85%) |
Filing History |
| 2024-02-09 09:16 am Purchase |
2024-02-08 | 13G | Ionis Pharmaceuticals, Inc. IONS |
FMR CORP | 21,520,872 15.000% |
213,353 (+1.00%) |
Filing History |
| 2024-01-26 4:25 pm Sale |
2023-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BLACKROCK INC BLK |
9,057,282 6.300% |
-125,629 (-1.37%) |
Filing History |
| 2023-06-09 2:15 pm Purchase |
2023-05-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
The Vanguard Group | 14,414,917 10.070% |
868,223 (+6.41%) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BB BIOTECH AG | 9,635,000 6.800% |
-597,973 (-5.84%) |
Filing History |
| 2023-02-14 12:40 pm Purchase |
2022-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
T. Rowe Price Investment Management, Inc. | 11,678,259 8.200% |
11,678,259 (New Position) |
Filing History |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Ionis Pharmaceuticals, Inc. IONS |
The Vanguard Group | 13,546,694 9.540% |
1,539,618 (+12.82%) |
Filing History |
| 2023-02-09 11:18 am Purchase |
2023-02-09 | 13G | Ionis Pharmaceuticals, Inc. IONS |
FMR CORP | 21,307,519 14.999% |
126,017 (+0.59%) |
Filing History |
| 2023-01-31 5:52 pm Purchase |
2022-12-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
BLACKROCK INC BLK |
9,182,911 6.500% |
643,629 (+7.54%) |
Filing History |
| 2022-08-10 2:56 pm Sale |
2022-07-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
PRICE T ROWE ASSOCIATES INC | 4,808,770 3.300% |
-9,541,690 (-66.49%) |
Filing History |
| 2022-04-11 11:13 am Purchase |
2022-03-31 | 13G | Ionis Pharmaceuticals, Inc. IONS |
PRICE T ROWE ASSOCIATES INC | 14,350,460 10.100% |
1,860,180 (+14.89%) |
Filing History |